WallStSmart

Elevance Health Inc (ELV)vsSumitomo Mitsui Financial Group Inc (SMFG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sumitomo Mitsui Financial Group Inc generates 2923% more annual revenue ($6.06T vs $200.42B). SMFG leads profitability with a 26.1% profit margin vs 2.6%. ELV appears more attractively valued with a PEG of 1.47. SMFG earns a higher WallStSmart Score of 70/100 (B-).

ELV

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 5.5Value: 6.7Quality: 6.0
Piotroski: 4/9Altman Z: 2.66

SMFG

Strong Buy

70

out of 100

Grade: B-

Growth: 8.0Profit: 8.0Value: 5.7Quality: 4.5
Piotroski: 5/9Altman Z: 0.34
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ELVUndervalued (+4.5%)

Margin of Safety

+4.5%

Fair Value

$416.35

Current Price

$415.53

$0.82 discount

UndervaluedFair: $416.35Overvalued

Intrinsic value data unavailable for SMFG.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ELV4 strengths · Avg: 8.3/10
Market CapQuality
$87.28B9/10

Large-cap with strong market position

P/E RatioValuation
17.0x8/10

Attractively priced relative to earnings

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$4.10B8/10

Generating 4.1B in free cash flow

SMFG6 strengths · Avg: 8.7/10
Free Cash FlowQuality
$7.34T10/10

Generating 7.3T in free cash flow

Market CapQuality
$151.34B9/10

Large-cap with strong market position

Profit MarginProfitability
26.1%9/10

Keeps 26 of every $100 in revenue as profit

P/E RatioValuation
15.5x8/10

Attractively priced relative to earnings

Price/BookValuation
1.5x8/10

Reasonable price relative to book value

Operating MarginProfitability
26.9%8/10

Strong operational efficiency at 26.9%

Areas to Watch

ELV3 concerns · Avg: 3.0/10
Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Profit MarginProfitability
2.6%3/10

2.6% margin — thin

EPS GrowthGrowth
-16.8%2/10

Earnings declined 16.8%

SMFG3 concerns · Avg: 2.3/10
PEG RatioValuation
2.034/10

Expensive relative to growth rate

Altman Z-ScoreHealth
0.342/10

Distress zone — elevated risk

Debt/EquityHealth
3.701/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : ELV

The strongest argument for ELV centers on Market Cap, P/E Ratio, Price/Book. PEG of 1.47 suggests the stock is reasonably priced for its growth.

Bull Case : SMFG

The strongest argument for SMFG centers on Free Cash Flow, Market Cap, Profit Margin. Profitability is solid with margins at 26.1% and operating margin at 26.9%. Revenue growth of 21.8% demonstrates continued momentum.

Bear Case : ELV

The primary concerns for ELV are Revenue Growth, Profit Margin, EPS Growth. Thin 2.6% margins leave little buffer for downturns.

Bear Case : SMFG

The primary concerns for SMFG are PEG Ratio, Altman Z-Score, Debt/Equity. Debt-to-equity of 3.70 is elevated, increasing financial risk.

Key Dynamics to Monitor

ELV profiles as a value stock while SMFG is a growth play — different risk/reward profiles.

ELV carries more volatility with a beta of 0.68 — expect wider price swings.

SMFG is growing revenue faster at 21.8% — sustainability is the question.

SMFG generates stronger free cash flow (7.3T), providing more financial flexibility.

Bottom Line

SMFG scores higher overall (70/100 vs 56/100), backed by strong 26.1% margins and 21.8% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Elevance Health Inc

HEALTHCARE · HEALTHCARE PLANS · USA

Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.

Sumitomo Mitsui Financial Group Inc

FINANCIAL SERVICES · BANKS - DIVERSIFIED · USA

Sumitomo Mitsui Financial Group, Inc. provides commercial banking, finance leasing, securities, consumer finance, and other services primarily in Japan. The company is headquartered in Tokyo, Japan.

Visit Website →

Want to dig deeper into these stocks?